Study of XL147 in Combination with Trastuzumab or Paclitaxel and Trastuzumab in Subjects with Metastatic Breast Cancer Who have Progressed on a Previous Trastuzumab-based Regimen - Stand Up To Cancer

Blog

Posted October 14, 2019

Study of XL147 in Combination with Trastuzumab or Paclitaxel and Trastuzumab in Subjects with Metastatic Breast Cancer Who have Progressed on a Previous Trastuzumab-based Regimen

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.